| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Division of Pulmonary Biology, Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039
Alveolar macrophages are essential for the maintenance of surfactant homeostasis. We asked whether surfactant treatment would change alveolar macrophage number and whether the alveolar macrophage phenotype would become activated or apoptotic when challenged in vivo with exogenous surfactant. Surfactant pool size in mice was increased by repetitive surfactant treatments containing 120 mg/kg (110 µmol/kg) saturated phosphatidylcholine. The number of alveolar macrophages recovered by alveolar lavage decreased after the first dose by 49% and slightly increased after the second and third doses. Up to 28.5% of the macrophages became large and foamy, and their appearance normalized within 12 h. Surfactant treatment did not increase the percent of apoptotic or necrotic cells. The alveolar macrophages were not activated as indicated by no change in expression of CD14, CD16, CD54, CD95, and scavenger receptor class A types I and II after surfactant treatment. Surfactant treatment in healthy mice transiently changed the phenotype of alveolar macrophages to large and foamy without indications of changes in the surface markers characteristic of activation.
surface markers; exogenous surfactant therapy; dipalmitoylphosphatidylcholine
This article has been cited by other articles:
|
|
 |
|
  M. Ikegami, E. A. Scoville, S. Grant, T. Korfhagen, W. Brondyk, R. K. Scheule, and J. A. Whitsett Surfactant Protein-D and Surfactant Inhibit Endotoxin-Induced Pulmonary Inflammation Chest, November 1, 2007; 132(5): 1447 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Forbes, M. Pickell, M. Foroughian, L.-J. Yao, J. Lewis, and R. Veldhuizen Alveolar macrophage depletion is associated with increased surfactant pool sizes in adult rats J Appl Physiol, August 1, 2007; 103(2): 637 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gille, B. Spring, W. Bernhard, C. Gebhard, D. Basile, K. Lauber, C. F. Poets, and T. W. Orlikowsky Differential effect of surfactant and its saturated phosphatidylcholines on human blood macrophages J. Lipid Res., February 1, 2007; 48(2): 307 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Poletti, G. Casoni, M. Chilosi, and M. Zompatori Diffuse panbronchiolitis Eur. Respir. J., October 1, 2006; 28(4): 862 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ikegami, K. Carter, K. Bishop, A. Yadav, E. Masterjohn, W. Brondyk, R. K. Scheule, and J. A. Whitsett Intratracheal Recombinant Surfactant Protein D Prevents Endotoxin Shock in the Newborn Preterm Lamb Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1342 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ikegami, J. A. Whitsett, P. C. Martis, and T. E. Weaver Reversibility of lung inflammation caused by SP-B deficiency Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L962 - L970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Clark, N. Palaniyar, P. Strong, J. Edmondson, S. Hawgood, and K. B. M. Reid Surfactant Protein D Reduces Alveolar Macrophage Apoptosis In Vivo J. Immunol., September 15, 2002; 169(6): 2892 - 2899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ikegami, W. M. Hull, M. Yoshida, S. E. Wert, and J. A. Whitsett SP-D and GM-CSF regulate surfactant homeostasis via distinct mechanisms Am J Physiol Lung Cell Mol Physiol, September 1, 2001; 281(3): L697 - L703. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
